News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Obagi Medical Products, Inc. (OMPI) Confirms Receipt of Directors Nomination Notice From Voce Capital


12/10/2012 9:57:22 AM

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. ("Obagi" or the "Company") (NASDAQ:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today confirmed that Voce Capital has submitted to the Company a notice of intent to nominate a slate of candidates to replace the Obagi Board of Directors at the Company’s 2013 Annual Meeting of Stockholders.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES